Article Details

2022 R&D Day Highlights Moderna's Broad Portfolio of mRNA Clinical Trial Programs

Retrieved on: 2022-09-14 03:42:27

Tags for this article:

Click the tags to see associated articles and topics

2022 R&D Day Highlights Moderna's Broad Portfolio of mRNA Clinical Trial Programs. View article details on hiswai:

Excerpt

... President Stephen Hoge, M.D., and Moderna clinical team leaders discussed the organization's advances across a portfolio of mRNA programs.

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up